AVA Genomics Consultancy ApS: Financial statements 2026
CVR: 37493678
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. That is a decrease of 87.5% compared with the year before. Equity in the 2026 report amounted to DKK 90,595. The solvency ratio was 99.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 14,728
- Profit/Loss
- DKK -4,294
- Equity
- DKK 90,595
- Total Assets
- DKK 90,858
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 15 t. | -4 t. | 91 t. | 1 |
| 2025 | - | 118 t. | -19 t. | 95 t. | 1 |
| 2024 | - | 433 t. | 251 t. | 234 t. | 1 |
| 2023 | - | -37 t. | -37 t. | -17 t. | - |
| 2022 | - | -19 t. | -20 t. | 20 t. | - |
Official annual report
Find more companies like AVA Genomics Consultancy ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.